Not only is Chembio among the walk's sponsors; company employees will also be participating in this historic walk to raise funds for AIDS research.
Published News
Chembio to Sponsor AIDS Walk New York 2010 | The Investor Relations Group
Posted by Janetvasquez 114 days ago (http://irgnews.com)Vaccines For HIV And AIDS On The Horizon | The Investor Relations Group
Posted by Janetvasquez 114 days ago (http://irgnews.com)
A company named GeoVax Labs, Inc. may be the first to put vaccines on the market that can help alleviate the suffering that results when HIV progresses to AIDS. Based in Smyrna, GA., the company is at work on both preventative and therapeutic vaccines.
Numerous Safety Warnings From FDA About These LABA Asthma Drugs Have Seemingly Been Ignored By Patients, According To New Medco Study
Fosamax, Boniva, And Other Drugs In This Class Are Under Scrutiny Due To This Emerging Drug Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com)
As effective as Gemcitabine is against some cancers, it has not been proven effective as a standalone treatment for eradicating certain other forms such as colon cancer. However, researchers at Weill Cornell Medical Center in New York have demonstrated that a reovirus therapy called REOLYSIN works synergistically with gemcitabine and may be worth further investigation.
Agents that Keep Insulin Working Longer
Posted by alex 114 days ago (http://www.diabetespubmed.com)
More than half a century after researchers identified a promising way to treat diabetes based on blocking the breakdown of insulin in the body, a research team led by a scientist at the Mayo Clinic campus in Florida have developed potent molecules that can do just that.
From Myopathy And Rhabdomyolysis To Tendon Ruptures And Interstitial Lung Disease
Two Clinical Studies Find Patients With Type 2 Diabetes Taking Benicar Had Higher Rate Of Death From A Cardiovascular Cause
New FDA Site Will Include A Summary Analysis Of Recently Reported Adverse Events And Related Medical Articles (Posted by Tom Lamb at DrugInjuryWatch.com)
Derma Sciences also announced that it has hired Maeve Kelly as Managing Director, EMEA (Europe, Middle East, Africa regions). Ms. Kelly will report directly to Barry J. Wolfenson, Executive Vice President of Global Marketing and Business Development.
Sort News
abbott
actavis
aids
alli
amgen
aranesp
astrazeneca
avandia
baxter
bayer
biotech
boehringer ingelheim
bristol-myers squibb
byetta
cancer
china
clinical
clinical trials
clothing
cnto411
conference
crestor
diabetes
digitek
drug
drug discovery
drug-injury
drug-safety
drugs
ec
electronic cigarette liquid
eli lilly
emarketing
emea
eu
eyeforpharma
fda
femur-fracture
fosamax
generic
generics
genzyme
glaxosmithkline
gsk
h1n1
health
health 2.0
heparin
industry leaders
insulin
intelligence
jacob fleming
jacob fleming group
januvia
jarvik
johnson & johnson
law
legal
lilly
lipitor
liver-failure
loans
lundbeck
manhattan research
medication-errors
merck
merck kgaa
nexavar
novartis
novo nordisk
nplate
nycomed
onj
pancreatitis
pfizer
pharma
pharmalot
preemption
raptiva
recall
research
roche
sandoz
sanofi-aventis
schering-plough
seroquel
shire
sprint-fidelis
summit
takeda
teva
training courses
transinsight
trasylol
vytorin
who
wyeth
yasmin
yaz
zetia